Does Rallies show 13F holders for INGN?

Yes. Rallies tracks hedge fund and 13F ownership data for INGN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is INGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INGN. It does not provide personalized investment advice.

INGN (Inogen Inc) Stock Analysis - Hedge Fund Holdings

Inogen Inc (INGN) is a publicly traded Healthcare sector company. As of May 21, 2026, INGN trades at $6.07 with a market cap of $170.57M and a P/E ratio of -6.88. INGN moved -1.71% today. Year to date, INGN is -4.66%; over the trailing twelve months it is +1.12%. Its 52-week range spans $5.34 to $12.91. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces INGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns INGN stock?

Hedge funds tracked by Rallies that own INGN include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Inogen Inc.

INGN Key Metrics

Key financial metrics for INGN
Metric	Value
Price	$6.07
Market Cap	$170.57M
P/E Ratio	-6.88
EPS	$-0.92
Dividend Yield	0.00%
52-Week High	$12.91
52-Week Low	$5.34
Volume	0
Avg Volume	0
Revenue (TTM)	$351.50M
Net Income	$-24.90M
Gross Margin	44.31%

Top Hedge Funds Holding INGN

Panagora Asset holds 46.22K shares of INGN, changed -4.10% as of Mar 31, 2026.

Latest INGN News

Inogen Narrows Q4 Loss to $0.15 EPS on 2% Revenue Growth, International Sales Up 14.8% — Feb 25, 2026
Inogen authorises $30M buyback after issuing 2026 outlook — Feb 24, 2026
Inogen Slumps 10% While Analysts Boost EPS Estimates 8.9% — Feb 10, 2026
Inogen Launches FDA-Cleared Aurora CPAP Masks After Successful 140-Patient Trial — Jan 8, 2026

Recent INGN Insider Trades

Bourque Michael J. bought 3.00K (~$24.96K) on Mar 3, 2025.
Smith Kevin Raymond Merrill bought 11.71K (~$100.25K) on Mar 3, 2025.
Somer Jason sold 10.00K (~$85.60K) on May 10, 2024.

INGN Analyst Consensus

2 analysts cover INGN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.

Common questions about INGN

Who owns INGN stock?: Hedge funds tracked by Rallies that own INGN include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Inogen Inc.
Does Rallies show 13F holders for INGN?: Yes. Rallies tracks hedge fund and 13F ownership data for INGN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is INGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INGN. It does not provide personalized investment advice.